Showing 5821-5830 of 5956 results for "".
- Surgeons from Vance Thompson Vision Make Impact with Mission Trip to Hondurashttps://modernod.com/news/surgeons-from-vance-thompson-vision-make-impact-with-mission-trip-to-honduras/2479985/This spring, Russell Swan, MD, led a team of surgeons from Vance Thompson Vision and the University of Iowa, plus staff members, on a mission trip to Honduras. Russell Swan, MD, John Berdahl, MD, Brandon Baartman, MD, and Dan Bettis, MD, were joined by five team members for a week-long sur
- Genentech Unveils New Clinical Data For the First Eye Implant for Wet AMDhttps://modernod.com/news/genentech-unveils-positive-phase-2-results-for-the-first-eye-implant-for-wet-amd/2479987/Genentech announced positive topline results from the phase 2 LADDER study evaluating the efficacy and safety of its investigational Port Delivery System (PDS) with ranibizumab in people with wet age-related macular degeneration (AMD). The small, refillable eye implant, which is slightly l
- Rayner’s New UK-Based Manufacturing Facility Receives FDA Approvalhttps://modernod.com/news/rayners-new-uk-based-manufacturing-facility-receives-fda-approval/2479988/The FDA has approved Rayner’s Ridley Innovation Centre, a $40 million purpose-built R&D, training and production facility in Worthing, UK, according to a company news release. This state-of-the-art, dedicated IOL production center has the capability of manufacturing 3 million IOLs each
- Aura Biosciences Presents Interim Phase 1b/2 Data at ASRShttps://modernod.com/news/aura-biosciences-presents-interim-phase-1b-2-data-at-asrs/2479994/Aura Biosciences presented interim data from an open-label phase 1b/2 study of its lead program, light-activated AU-011 for the treatment of primary choroidal melanoma, at the 36th annual American Society of Retina Specialists (ASRS) meeting in Vancouver, Canada. The findings were presented by Am
- EyeGate Announces FDA Approval of Two IDE Submissions for Ocular Bandage Gelhttps://modernod.com/news/eyegate-announces-fda-approval-of-two-ide-submissions-for-ocular-bandage-gel/2479995/EyeGate Pharmaceuticals announced the FDA has approved two of EyeGate’s investigational device exemption (IDE) applications for pilot studies of the company’s Ocular Bandage Gel (OBG) product for the acceleration of reepithelialization of large corneal epithelial defects in patients having underg
- Thomas A. Finley, MD, Appointed Chairmen of Ocutrx International Medical Advisory Boardhttps://modernod.com/news/thomas-a-finley-md-appointed-chairmen-of-ocutrx-international-medical-advisory-board/2479996/Ocutrx Vision Technologies, a California-based augmented reality (AR) glasses developer announced that Thomas A. Finley, MD, will serve as the Chairman of the Ocutrx International Medical Advisory Board (IMAB). The board serves to advise Ocutrx in its development of augmented reality glasses for
- Alcon Unveils Next-Generation Forceps to Improve Precision and Reduce Trauma During Retina Surgeryhttps://modernod.com/news/alcon-unveils-next-generation-forceps-to-improve-precision-and-reduce-trauma-during-retina-surgery/2479998/Alcon has launched the new Finesse Sharkskin ILM Forceps at the the American Society of Retina Specialists (ASRS) meeting. The next-generation tool is designed to provide increased surgical precision and to enhance retina surgery outcomes. The new forceps have a large grasping platform and a text
- Aerie Pharmaceuticals Announces Early Notification of FDA Acceptance of NDA Submission for Roclatanhttps://modernod.com/news/aerie-pharmaceuticals-announces-early-notification-of-fda-acceptance-of-nda-submission-for-roclatan/2479999/Aerie Pharmaceuticals reported that it has received the “Day 74” notification from the FDA earlier than scheduled. The FDA has completed its initial 60-day review of the new drug application (NDA) for Roclatan (netarsudil/latanoprostnetarsudil ophthalmic solution) 0.02%/0.005% and the FDA has det
- Allergan and Molecular Partners Announce Positive Phase 3 Clinical Trials for Abicipar Pegol for the Treatment of Wet AMDhttps://modernod.com/news/allergan-and-molecular-partners-announce-positive-phase-3-clinical-trials-for-abicipar-pegol-for-the-treatment-of-wet-amd/2480008/Allergan and Molecular Partners announced the release of two positive clinical trials, SEQUOIA and CEDAR, for abicipar, demonstrating that both the 8-week and 12-week treatment regimens met the prespecified primary endpoint of noninferiority to ranibizumab. SEQUOIA and CEDAR are identical
- FDA Releases Action Plan to Speed Up Market Entry for Biosimilarshttps://modernod.com/news/fda-releases-action-plan-to-speed-up-market-entry-for-biosimilars/2480010/The FDA unveiled plans Wednesday designed to facilitate the development, approval and market entry of biosimilars in the US. The Biosimilars Action Plan (BAP) “is aimed at promoting competition and affordability across the market for biologics and biosimilar products,” commented FDA C